T. Lamy
45 Papers
364 Citations
T. Lamy is an academic researcher. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 15, co-authored 29 publications.
Chat about Author
Papers
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
Benjamin Hebraud,Xavier Leleu,Valérie Lauwers-Cances,Murielle Roussel,Denis Caillot,Gerald Marit,Lionel Karlin,C. Hulin,C Gentil,François Guilhot,Laurent Garderet,T. Lamy,Sabine Brechignac,Brigitte Pegourie,Jérôme Jaubert,Mamoun Dib,Stoppa Am,Catherine Sebban,Cecile Fohrer,Jean Fontan,Christophe Fruchart,Margaret Macro,Frédérique Orsini-Piocelle,Gérard Lepeu,Claudine Sohn,Jill Corre,Thierry Facon,Philippe Moreau,M. Attal,Hervé Avet-Loiseau +29 more
TL;DR: The data show that 1p22 and 1p32 deletions are major negative prognostic factors for PFS and OS for patients with MM, and it is suggested that 1 p32 deletion should be tested for all patients at diagnosis.
101
Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
TL;DR: The treatment was found to be effective and well tolerated, offering a good alternative to hospitalization during a transient chemotherapy-induced neutropenia.
85
Interim report from a phase 2 multicenter study of tazemetostat, an ezh2 inhibitor, in patients with relapsed or refractory b-cell non-hodgkin lymphomas
Franck Morschhauser,Gilles Salles,P. McKay,H. Tilly,Anna Schmitt,John F. Gerecitano,Peter Johnson,S. Le Gouill,Michael Dickinson,Christophe Fruchart,T. Lamy,Aristeidis Chaidos,Wojciech Jurczak,Stephen Opat,John Radford,P. L. Zinzani,Sarit Assouline,Guillaume Cartron,Alicia Clawson,N. Picazio,S. Ribich,Stephen J. Blakemore,John Larus,Harry Miao,Peter T.C. Ho,Vincent Ribrag +25 more
62
Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial.
Eric Deconinck,T. Lamy,Charles Foussard,Fanny Gaillard,Vincent Delwail,Philippe Colombat,Philippe Casassus,A Lemevel,Annie Brion,Noel-Jean Milpied +9 more
TL;DR: Intensified chemotherapy with autologous stem cell support appeared effective in the treatment of ALCL, offering patients the real chance of a cure.
58
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience.
Hervé Avet-Loiseau,Murielle Roussel,Loïc Campion,Xavier Leleu,Gerald Marit,H. Jardel,Mamoun Dib,Olivier Decaux,T. Lamy,Mourad Tiab,Pascale Cony-Makhoul,Anne Banos,Gérard Lepeu,François Lifermann,Margaret Macro,Brigitte Kolb,C. Hulin,Denis Caillot,Catherine Traullé,Claire Mathiot,Bruno Royer +20 more
TL;DR: Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience and implications for clinical practice and drug discovery.
50